|
Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health systems |
Medicines for Europe |
16 Dec 2021 |
Health & Consumers |
|
Billions more euros to re-invest in better healthcare thanks to biosimilar medicines |
Medicines for Europe |
14 Dec 2022 |
Health & Consumers |
|
Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe |
Medicines for Europe |
01 Oct 2021 |
Health & Consumers |
|
AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” |
Medicines for Europe |
03 Feb 2021 |
Health & Consumers |
|
Adjustments to IP framework needed to improve access to medicines in Europe |
Medicines for Europe |
16 Nov 2021 |
Science & Policymaking |
|
Addressing medicine shortages in Europe: Competition is crucial for patient access |
Medicines for Europe |
29 Sep 2017 |
Health & Consumers, Competition |
|
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest |
Medicines for Europe |
14 Jun 2018 |
Health & Consumers |
|
Access to medicines critical in European Parliament vote on EU IP action plan |
Medicines for Europe |
12 Nov 2021 |
Health & Consumers |
|
Access to medicines and security of supply should be central to EU pharma and IP legislation reforms in Europe |
Medicines for Europe |
13 Jun 2023 |
Health & Consumers |
|
Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries |
Medicines for Europe |
26 Nov 2021 |
Health & Consumers |
|
A streamlined, digital regulatory framework is the foundation for equitable access to medicines |
Medicines for Europe |
27 Sep 2023 |
Health & Consumers |
|
A step forward for the secure supply of medicines and manufacturing and for public health |
Medicines for Europe |
25 Oct 2023 |
Health & Consumers |
|
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector |
Medicines for Europe |
24 Sep 2019 |
Health & Consumers |
|
62% of Medicines Dispensed in Europe are Generic, according to IMS New Data |
Medicines for Europe |
15 Jun 2017 |
Health & Consumers |
|
2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic |
Medicines for Europe |
05 Dec 2022 |
Health & Consumers |
|
2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems |
Medicines for Europe |
25 Jan 2018 |
Health & Consumers |
|
2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments |
Medicines for Europe |
12 Sep 2017 |
Health & Consumers |
|
A new medicines trade and health security agenda for the European Commission |
Medicines for Europe |
19 Feb 2021 |
Health & Consumers |
